Target intelligence / Profile preview

Pseudogene similar to part of nucleostemin

Molecular classification
Pseudogene, Noncoding RNA
01

Overview

ENSG00000224493 refers to a sequence annotated as a “pseudogene similar to part of nucleostemin.” Pseudogenes are genomic sequences that closely resemble functional genes but are incapable of encoding functional proteins, typically due to disabling mutations or absence of regulatory elements[2][4]. The parental gene, nucleostemin (GNL3), is involved in cell cycle regulation and is a marker of stem and cancer cells[7]. While some pseudogenes exert regulatory effects on their parental genes (such as through noncoding RNA products), there is no experimentally validated function or disease association for this particular pseudogene[1][3][6][5][8]. It is not considered a therapeutic target, nor does it encode a receptor, enzyme, transporter, or similar druggable protein. Pseudogene annotations like this one may have research relevance, especially for studies of noncoding RNAs or regulatory genomics, but they currently lack direct clinical or translational significance.

Other names
ENSG00000224493Pseudogene Similar To Part Of Nucleostemin
02

Biological functions

Possible regulatory RNA function by sequence similarity to the parental geneOccasionally, pseudogenes may have regulatory roles such as miRNA sponging, antisense interaction, or other forms of gene regulation, but no specific function is documented for this pseudogene
03

Disease associations

Pseudogenes can sometimes play a role in disease, especially when they regulate their parental genes, but there is no evidence or annotation for this specific pseudogene in disease processes

Beyond the preview

Go deeper on Pseudogene similar to part of nucleostemin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of nucleostemin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call